DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Menu 返回 Pharmacovigilance-and-Safety

Pharmacovigilance & Safety

This track provides an overview of, and insight into, the global patient safety environment for medicinal products and medical devices. The focus is on pragmatic vision for ensuring patient safety and ensuring that the patient voice is properly heard in the complex and evolving safety ecosystem. The forward-thinking sessions will address the complexities of operating in a global environment and look at how we apply new technologies and methods for streamlining safety systems and processes. This will help enhance patient safety as products become progressively more complex, new data sources drive new analytical techniques and regulatory requirements.

Who is This Track Designed For?

Anyone curious/interested, established safety professionals who are seeking to increase their network of like-minded colleagues; share their thoughts and practices with others; learn the most current safety regulatory views and gain practical knowledge in key areas in pharmacovigilance.

25101-175w

The online program is now available. Explore the rich content we offer across 10 thought leadership tracks. 

View Searchable Programme

Topic Leader

James Whitehead

James Whitehead

Senior Director, Device & Digital Safety

AstraZeneca, United Kingdom

Willemijn van der Spuij

Willemijn van der Spuij

Executive Director, WorldWide Patient Safety International, Europe

Bristol Myers Squibb, Switzerland

View Pharmacovigilance & Safety Sessions

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。